Multivariate AnalysisMetabolomicsPrincipal Component AnalysisMetabolomeDiscriminant AnalysisPrognosisMass SpectrometryCluster AnalysisRisk FactorsRetrospective StudiesTreatment OutcomeSurvival AnalysisProspective StudiesFollow-Up StudiesSurvival RateTime FactorsPredictive Value of TestsLogistic ModelsProportional Hazards ModelsCohort StudiesAge FactorsNeoplasm StagingCross-Sectional StudiesKaplan-Meier EstimateDisease-Free SurvivalAnalysis of VarianceRegression AnalysisTumor Markers, BiologicalCase-Control StudiesRisk AssessmentPrevalenceOdds RatioQuestionnairesReproducibility of ResultsChi-Square DistributionSex FactorsData Interpretation, StatisticalModels, StatisticalIncidenceSeverity of Illness IndexBreast NeoplasmsNeoplasm Recurrence, LocalImmunohistochemistryLymphatic MetastasisBiological MarkersRecurrenceUnited StatesDisease ProgressionSensitivity and SpecificityAlgorithmsStatistics as TopicLinear ModelsSocioeconomic FactorsROC CurveCombined Modality TherapyBrazilEpidemiologic MethodsInfant, NewbornPostoperative ComplicationsGenotypeProbabilityAdenocarcinomaStatistics, NonparametricSmokingJapanComorbidityLongitudinal StudiesLiver NeoplasmsLung NeoplasmsHIV InfectionsAntineoplastic Combined Chemotherapy ProtocolsRiskBody Mass IndexChinaIndiaItalyNeoplasm InvasivenessFranceGene Expression ProfilingColorectal NeoplasmsPregnancyConfidence IntervalsDemographyCarcinoma, Squamous CellRegistriesAge DistributionDatabases, FactualMagnetic Resonance ImagingTissue Array AnalysisStomach NeoplasmsSpainKi-67 AntigenChemotherapy, AdjuvantHospital MortalityOligonucleotide Array Sequence AnalysisNeoplasm GradingChronic DiseaseCarcinoma, HepatocellularNeoplasm MetastasisTreatment Failure